Related Experiment Videos
Infectious mononucleosis. Complexities of a common syndrome
1Department of Family and Community Medicine, Lancaster General Hospital, PA 17604-3555, USA.
Abstract:
Infectious mononucleosis is common in adolescents and young adults. Although the syndrome is most often associated with Epstein-Barr virus, several other organisms can also cause infectious mononucleosis. Diagnosis is based on clinical findings and the presence of heterophil antibodies and atypical lymphocytes. Diagnosis may be more difficult in older adults because the presenting symptoms often differ from those seen in children. Symptoms usually resolve in 2 to 3 weeks. Treatment of uncomplicated infectious mononucleosis is supportive, but corticosteroids may be beneficial for the treatment of several complications associated with Epstein-Barr virus. Physically active patients should be counseled about the risks of splenic injury.
Insights
Infectious mononucleosis, often called mono, is common in young people. While Epstein-Barr virus is the usual cause, other organisms can also cause it, and treatment is typically supportive.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- Infectious mononucleosis (IM) is a common clinical syndrome.
- While Epstein-Barr virus (EBV) is the most frequent cause, other viruses and bacteria can also cause IM.
- Diagnosis can be challenging, especially in older adults due to atypical presentations.
Purpose of the Study:
- To provide a comprehensive overview of infectious mononucleosis.
- To highlight diagnostic criteria and challenges.
- To discuss management strategies and potential complications.
Main Methods:
- Review of clinical findings.
- Serological testing for heterophil antibodies.
- Peripheral blood smear analysis for atypical lymphocytes.
Main Results:
- IM commonly affects adolescents and young adults.
- Diagnosis relies on clinical signs, heterophil antibodies, and atypical lymphocytes.
- Symptoms typically resolve within 2-3 weeks.
Conclusions:
- Supportive care is the mainstay for uncomplicated IM.
- Corticosteroids may be useful for managing EBV-associated complications.
- Patient education regarding splenic rupture risk is crucial, especially for active individuals.